Echinacea Xtreme

by Mountain Meadow Herbs · liquid · 4 fluid ounces

  • On the market (NIH)
  • UPC 8 13086 01669 4
  • DSLD label 267724
  • Serving 0.13 to 0.25 tsps (1 dropperful = Approx. 1/8 tsp); amounts per 0.25 tsps
  • 96 servings

Echinacea Xtreme by Mountain Meadow Herbs lists 2 ingredients; 2 sit inside a blend without their own amounts. Its current label entered the NIH Dietary Supplement Label Database on June 16, 2022.

What is in Echinacea Xtreme?

Each row as the label prints it, per serving of 0.25 tsps. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Echinacea Xtreme: Supplement Facts rows against the market (DSLD label 267724, January 2026 release)
IngredientAmount% DVAmong products listing it
Proprietary Blend1.25 mL
Echinacea angustifoliain the blend, no amount given
Echinacea purpureain the blend, no amount given

Source: NIH ODS Dietary Supplement Label Database, label 267724 (entered June 16, 2022), version 9.4.0. See the label on DSLD or its label image (PDF). Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient; 2 ingredients sit inside a blend, so their amounts cannot be compared.

The NIH database records 1 to 3 servings a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

6 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Suggested Use: 0-2 yrs: 5-10 drops. 3-11 yrs: 1/8 tsp. 12+ yrs: 1/4 tsp. Take 1-3 times daily, or as needed.
Shake well.
Warnings
Caution: If you are pregnant, nursing, have a medical condition, or are taking a prescription, consult your health care provider before using this product.
Keep out of reach of children.
Allergens and what it does not contain
Alcohol free
GF (Gluten free) Sugar free
Storage
Store in a cool, dry place out of sunlight.

Source: label statements in DSLD label 267724.

What else is on the label?

Other ingredients: Vegetable Glycerin, distilled Water.

Seals and symbols as the label prints them (the maker's; a certifier's own list confirms a seal): Made in Montana USA.

How many labels does Echinacea Xtreme have?

2 labels are on file under this name since April 11, 2022: other sizes, label designs and reformulations. The current one leads this page.

  1. Label 267724 (current) Entered June 16, 2022 · on the market · 4 fluid ounces · UPC 8 13086 01669 4
  2. Label 267521 Entered April 11, 2022 · on the market · 2 fluid ounces · UPC 8 13086 01668 7

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Mountain Meadow Herbs, Inc. (manufacturer, distributor), Somers, MT. All Mountain Meadow Herbs products.

Where next?